1
|
NCCN clinical practice guidelines in oncology: hepatobiliary cancers.
|
J Natl Compr Canc Netw
|
2009
|
3.25
|
2
|
Virologic response and resistance to adefovir in patients with chronic hepatitis B.
|
J Hepatol
|
2005
|
2.04
|
3
|
Novel fucosylated biomarkers for the early detection of hepatocellular carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2009
|
1.79
|
4
|
Treatment of primary biliary cirrhosis with tetrathiomolybdate: results of a double-blind trial.
|
Transl Res
|
2009
|
1.40
|
5
|
Percutaneous radiofrequency thermal ablation of hepatocellular carcinoma: a safe and effective bridge to liver transplantation.
|
Liver Transpl
|
2002
|
1.14
|
6
|
Identification and confirmation of biomarkers using an integrated platform for quantitative analysis of glycoproteins and their glycosylations.
|
J Proteome Res
|
2010
|
1.05
|
7
|
Analysis of serum haptoglobin fucosylation in hepatocellular carcinoma and liver cirrhosis of different etiologies.
|
J Proteome Res
|
2014
|
1.05
|
8
|
Cleavage of endoplasmic reticulum proteins in hepatocellular carcinoma: Detection of generated fragments in patient sera.
|
Gastroenterology
|
2006
|
1.05
|
9
|
The degree of readiness of selected biomarkers for the early detection of hepatocellular carcinoma: notes from a recent workshop.
|
Cancer Biomark
|
2008
|
1.01
|
10
|
Comparison of imputation methods for missing laboratory data in medicine.
|
BMJ Open
|
2013
|
1.01
|
11
|
Bacteremic pneumococcal infections in immunocompromised patients without AIDS: the impact of beta-lactam resistance on mortality.
|
Int J Infect Dis
|
2003
|
0.88
|
12
|
Incidence and risk factors of hepatocellular carcinoma recurrence after liver transplantation in the MELD era.
|
Dig Dis Sci
|
2011
|
0.88
|
13
|
Interleukin-6 and oncostatin M are elevated in liver disease in conjunction with candidate hepatocellular carcinoma biomarker GP73.
|
Cancer Biomark
|
2012
|
0.88
|
14
|
Novel changes in glycosylation of serum Apo-J in patients with hepatocellular carcinoma.
|
Cancer Epidemiol Biomarkers Prev
|
2011
|
0.87
|
15
|
Mass-selected site-specific core-fucosylation of ceruloplasmin in alcohol-related hepatocellular carcinoma.
|
J Proteome Res
|
2014
|
0.86
|
16
|
Aasld guidelines for the treatment of hepatocellular carcinoma.
|
Hepatology
|
2017
|
0.83
|
17
|
A comparison of statistical methods for the detection of hepatocellular carcinoma based on serum biomarkers and clinical variables.
|
BMC Med Genomics
|
2013
|
0.81
|
18
|
Altered functionality of anti-bacterial antibodies in patients with chronic hepatitis C virus infection.
|
PLoS One
|
2013
|
0.79
|
19
|
Improved biomarker performance for the detection of hepatocellular carcinoma by inclusion of clinical parameters.
|
Proceedings (IEEE Int Conf Bioinformatics Biomed)
|
2012
|
0.78
|